Deciphering the steps of prodiginine biosynthesis

破译原地吉宁生物合成步骤

基本信息

  • 批准号:
    7849695
  • 负责人:
  • 金额:
    $ 58.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-01 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Prodiginines are a family of linear and cyclic oligopyrrole red-pigmented antibiotics produced by actinomycetes and other eubacteria. Members of this class of antibiotics have been known for some time, as have their broad antifungal, antibacterial activity. There has been a dramatic interest in recent years in these natural products as they appear to have pronounced antimalarial, anticancer and immunosuppressant activity. We have used a series of genetic and biochemical experiments to reveal that a cluster of 23 red genes in Streptomyces coelicolor genome encode a fascinating and unusual pathway leading to formation of undecylprodiginine and a cyclized derivative, streptorubin B. The initial stages of this process involve a complex interface with fatty acid biosynthesis which will be further investigated in specific aim 1. Subsequent stages involve numerous multifunctional and monofunctional proteins with unusual architecture and catalytic activities and specific aims 2-4 will be a continuation of our studies on these. Our preliminary work has also demonstrated that we can generate novel cyclic and linear prodiginine analogues in S. coelicolor by either feeding analogues of pathway intermediates to the appropriate blocked mutants, or creation of hybrid biosynthetic pathways (exchanging Red proteins with proteins of similar catalytic activity but different substrate specificities). Specific aim 5 will build on these successes generating additional novel prodiginine structures and evaluating their biological activity in antimalarial, immunosuppressant, anticancer and antifungal assays. A wide array of chemical, genetic and biochemical approaches will be used for these 5 specific aims which address our long term objective of a) building a comprehensive understanding of the enzymology of prodiginine biosynthetic pathways and b) using this knowledge to generate novel linear and cyclic prodiginines structures for potential application in human health. Lay Language Description. Some bacteria produce bright red pigments (prodiginines) which show promise for numerous human health applications including cancer treatment, fighting malaria and other infectious diseases, and helping organ transplant patients. This work will identify how these prodiginines are made by the bacteria and use this knowledge to generate and identify new prodiginines with the correct chemical properties and biological activities for possible clinical development.
描述(由申请方提供):原青霉素是由放线菌和其他真细菌产生的线性和环状低聚吡咯红色抗生素家族。这类抗生素的成员已经知道了一段时间,因为它们具有广泛的抗真菌,抗细菌活性。近年来,人们对这些天然产品产生了极大的兴趣,因为它们似乎具有明显的抗疟疾、抗癌和免疫抑制活性。我们通过一系列的遗传和生化实验揭示天蓝色链霉菌基因组中的一组23个红色基因编码一个有趣的和不寻常的途径,导致形成十一烷基普地吉宁和环化衍生物链脲菌素B。该过程的初始阶段涉及与脂肪酸生物合成的复杂界面,这将在具体目标1中进一步研究。随后的阶段涉及许多多功能和单功能蛋白质与不寻常的架构和催化活性和具体目标2-4将是我们对这些研究的继续。我们的初步工作也表明,我们可以在S.通过将途径中间体的类似物喂入适当的阻断突变体,或创建杂交生物合成途径(将Red蛋白与具有相似催化活性但不同底物特异性的蛋白交换),来合成腔棘鱼。具体目标5将建立在这些成功的基础上,产生额外的新的Prodiginine结构,并评价其在抗疟疾、免疫抑制剂、抗癌和抗真菌试验中的生物活性。一系列广泛的化学、遗传和生物化学方法将用于这5个特定目标,这些目标解决了我们的长期目标:a)建立对前体生物合成途径酶学的全面理解,以及B)利用这些知识产生新的线性和环状前体结构,用于人类健康的潜在应用。Lay语言描述。一些细菌产生明亮的红色色素(Prodiginines),这些色素显示出许多人类健康应用的前景,包括癌症治疗,抗击疟疾和其他传染病,以及帮助器官移植患者。这项工作将确定这些前体是如何由细菌制造的,并利用这些知识来产生和鉴定具有正确化学性质和生物活性的新前体,以用于可能的临床开发。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification and Characterization of FabA from the Type II Fatty Acid Synthase of Streptomyces coelicolor.
天蓝色链霉菌 II 型脂肪酸合酶 FabA 的鉴定和表征。
  • DOI:
    10.1021/acs.jnatprod.5b00560
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Singh,Renu;Reynolds,KevinA
  • 通讯作者:
    Reynolds,KevinA
Regio- and stereodivergent antibiotic oxidative carbocyclizations catalysed by Rieske oxygenase-like enzymes.
  • DOI:
    10.1038/nchem.1024
  • 发表时间:
    2011-05
  • 期刊:
  • 影响因子:
    21.8
  • 作者:
  • 通讯作者:
Antimalarial activity of natural and synthetic prodiginines.
  • DOI:
    10.1021/jm200543y
  • 发表时间:
    2011-08-11
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Papireddy, Kancharla;Smilkstein, Martin;Kelly, Jane Xu;Shweta;Salem, Shaimaa M.;Alhamadsheh, Mamoun;Haynes, Stuart W.;Challis, Gregory L.;Reynolds, Kevin A.
  • 通讯作者:
    Reynolds, Kevin A.
Mechanism and Catalytic Diversity of Rieske Non-Heme Iron-Dependent Oxygenases.
  • DOI:
    10.1021/cs400087p
  • 发表时间:
    2013-10-04
  • 期刊:
  • 影响因子:
    12.9
  • 作者:
    Barry, Sarah M.;Challis, Gregory L.
  • 通讯作者:
    Challis, Gregory L.
Stereospecific synthesis of 23-hydroxyundecylprodiginines and analogues and conversion to antimalarial premarineosins via a Rieske oxygenase catalyzed bicyclization.
  • DOI:
    10.1021/jo5023553
  • 发表时间:
    2014-12-05
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kancharla P;Lu W;Salem SM;Kelly JX;Reynolds KA
  • 通讯作者:
    Reynolds KA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEVIN A REYNOLDS其他文献

KEVIN A REYNOLDS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEVIN A REYNOLDS', 18)}}的其他基金

Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation
潮霉素 A:活性、生物合成、输出、耐药性和监管
  • 批准号:
    8537947
  • 财政年份:
    2011
  • 资助金额:
    $ 58.5万
  • 项目类别:
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation
潮霉素 A:活性、生物合成、输出、耐药性和监管
  • 批准号:
    8727602
  • 财政年份:
    2011
  • 资助金额:
    $ 58.5万
  • 项目类别:
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation
潮霉素 A:活性、生物合成、输出、耐药性和监管
  • 批准号:
    8023746
  • 财政年份:
    2011
  • 资助金额:
    $ 58.5万
  • 项目类别:
Hygromycin A: Activity, Biosynthesis, Export, Resistance and Regulation
潮霉素 A:活性、生物合成、输出、耐药性和监管
  • 批准号:
    8335367
  • 财政年份:
    2011
  • 资助金额:
    $ 58.5万
  • 项目类别:
Deciphering the steps of prodiginine biosynthesis
破译原地吉宁生物合成步骤
  • 批准号:
    7414458
  • 财政年份:
    2007
  • 资助金额:
    $ 58.5万
  • 项目类别:
Deciphering the steps of prodiginine biosynthesis
破译原地吉宁生物合成步骤
  • 批准号:
    7634480
  • 财政年份:
    2007
  • 资助金额:
    $ 58.5万
  • 项目类别:
Deciphering the steps of prodiginine biosynthesis
破译原地吉宁生物合成步骤
  • 批准号:
    7914938
  • 财政年份:
    2007
  • 资助金额:
    $ 58.5万
  • 项目类别:
Deciphering the steps of prodiginine biosynthesis
破译原地吉宁生物合成步骤
  • 批准号:
    7264876
  • 财政年份:
    2007
  • 资助金额:
    $ 58.5万
  • 项目类别:
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
3-酮脂酰 ACP 合酶 III:新型抗生素靶点
  • 批准号:
    7095655
  • 财政年份:
    2005
  • 资助金额:
    $ 58.5万
  • 项目类别:
3-Ketoacyl ACP Synthase III: A Novel Antibiotic Target
3-酮脂酰 ACP 合酶 III:新型抗生素靶点
  • 批准号:
    7026511
  • 财政年份:
    2005
  • 资助金额:
    $ 58.5万
  • 项目类别:

相似海外基金

Development of anti-scirrhous stomach cancer produced by the deep-sea actinomyces
深海放线菌抗硬胃癌的开发
  • 批准号:
    21H03007
  • 财政年份:
    2021
  • 资助金额:
    $ 58.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Comprehensive analysis of the fluoride-effects on the metabolic mechanism of oral Actinomyces
氟对口腔放线菌代谢机制影响的综合分析
  • 批准号:
    16K20447
  • 财政年份:
    2016
  • 资助金额:
    $ 58.5万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Breakthrough of fluoride-functional mechanism and establishment of its utilization for oral Actinomyces
氟作用机制的突破及其在口腔放线菌中的应用
  • 批准号:
    25861783
  • 财政年份:
    2013
  • 资助金额:
    $ 58.5万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The role of the initial colonizer Actinomyces oris in dental plaque formation.
初始定殖者口放线菌在牙菌斑形成中的作用。
  • 批准号:
    24592790
  • 财政年份:
    2012
  • 资助金额:
    $ 58.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome sequencing and mutational analysis of the Actinomyces strains with enhanced biofilm phenotype
具有增强生物膜表型的放线菌菌株的基因组测序和突变分析
  • 批准号:
    23792118
  • 财政年份:
    2011
  • 资助金额:
    $ 58.5万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    8774895
  • 财政年份:
    2008
  • 资助金额:
    $ 58.5万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    10455056
  • 财政年份:
    2008
  • 资助金额:
    $ 58.5万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    8588304
  • 财政年份:
    2008
  • 资助金额:
    $ 58.5万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    7783826
  • 财政年份:
    2008
  • 资助金额:
    $ 58.5万
  • 项目类别:
Molecular Assembly on the Cell Surface of Actinomyces
放线菌细胞表面的分子组装
  • 批准号:
    7373000
  • 财政年份:
    2008
  • 资助金额:
    $ 58.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了